| Kathleen Stewart, MA CCC-SLP | |
|
395 S Troy St, Aurora, CO 80012-2472 | |
| (303) 366-9594 | |
| Not Available |
| Full Name | Kathleen Stewart |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 395 S Troy St, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205602703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Stewart, MA CCC-SLP 395 S Troy St, Aurora, CO 80012-2472 Ph: (303) 366-9594 | Kathleen Stewart, MA CCC-SLP 395 S Troy St, Aurora, CO 80012-2472 Ph: (303) 366-9594 |
News Archive
A dietary supplement manufacturer and two of its executives have been ordered by a federal court to stop manufacturing, holding, or distributing any articles of food, including dietary supplements, until they come into compliance with federal dietary supplement current good manufacturing practice regulations and other Federal Food, Drug, and Cosmetic Act (FD&C Act) requirements.
EndyMed Medical, Ltd., a leader in the use of multi-source radiofrequency for professional aesthetic treatments, announced today the publication of the latest peer reviewed paper on 3DEEP radiofrequency technology, "A novel method for real-time skin impedance measurement during radiofrequency skin tightening treatments".
People taking the protein supplement L-norvaline should be aware of its potential for harm, scientists say. L-norvaline is an ingredient widely used in body building supplements and is promoted as a compound that can boost workouts and aid recovery.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
› Verified 2 days ago
Miss Elizabeth Frances Peterson, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 S Parker Rd Ste 336, Aurora, CO 80014 Phone: 303-330-3309 Fax: 303-862-9770 | |
Rebecca Aragon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Kristina Hess, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Geneva St, Aurora, CO 80010 Phone: 303-364-9311 | |
Elizabeth Marie Cuadrado, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1635 Aurora Court, 6th Floor, Ms F737, Aurora, CO 80045 Phone: 954-735-6000 | |
Cheryl Anselmo, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Box 030, Aurora, CO 80045 Phone: 720-777-6085 | |
Mrs. Melanie Lynn Wiseman, M.S. SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2851 S Parker Rd Ste 570, Aurora, CO 80014 Phone: 303-888-4840 | |
Chloe Mizusawa, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10100 E 13th Ave, Aurora, CO 80010 Phone: 303-366-2671 |